Abbreviations used in this paper: MTOC, microtubule organizing center; PKD1, protein kinase D1; PMA, phorbol myristate acetate; ROCK, Rho kinase; shRNA, short hairpin RNA; ts, temperature-sensitive; VSVG, vesicular stomatitis virus G protein.

Introduction
============

A detailed molecular understanding of the mechanisms by which cells migrate is important not only to our view of normal physiological processes, such as embryonic development and wound repair, but also to our ability to intervene in the progression of inflammatory disease and cancer. The integrin family of heterodimeric matrix receptors plays a central role in normal and pathophysiological modes of cell migration by acting not only to physically couple cells to the ECM but also to function as signaling molecules that transmit information across the plasma membrane ([@bib12]). Of the numerous intracellular signaling events that are triggered by integrin engagement, perhaps the most pertinent to cell migration is their capacity to influence cytoskeletal dynamics via the activation of Rho subfamily GTPases ([@bib6]; [@bib2]). Indeed, cells can use different migrational modes to move with varying degrees of speed and directionality depending on the nature of Rho GTPase signaling downstream of integrins. For instance, metastasizing tumor cells often move randomly and rapidly undergo amoeboid shape changes, and this depends on the ability of β1 integrins to activate Rho kinase (ROCK) via the small GTPase, RhoA ([@bib29]). Alternatively, during processes such as wound healing, fibroblasts migrate directionally and with high persistence (i.e., the tendency to continue traveling in the same direction without turning), and this can be determined by the degree of Rac signaling downstream of α5β1 integrin ([@bib19]).

To an extent, patterns of migratory behavior are dictated by characteristics that are intrinsic to particular cell types. However, both normal cells and those derived from tumors can switch between different modes of migration, and signaling pathways activated downstream of integrins can contribute to this. For instance, epithelial cells expressing αvβ3 integrin migrate persistently, but the same cells migrate randomly upon expression of the α5β1 heterodimer ([@bib7]). This is a consequence of the ability of α5β1 to activate ROCK, which in turn phosphorylates and inhibits the actin-severing protein cofilin.

Several integrins engage in endo--exocytic cycling, and many of the Rab GTPases and kinases that control their return to the plasma membrane are now becoming clear ([@bib5]; [@bib14]). α5β1 integrin recycles to the plasma membrane from a perinuclear recycling compartment via a "long-loop" pathway requiring Rab11 and activity of the PKB/GSK-3β axis ([@bib24]). Conversely, αvβ3 integrin travels more rapidly back to the cell surface via a "short loop" that is controlled by Rab4 and requires association of protein kinase D1 (PKD1) with the integrin ([@bib31]). Receptors for growth factors and chemokines are also endocytosed and then recycled back to the cell surface, and it is now clear that this process influences the way they signal ([@bib17]). Indeed, many receptors remain competent to signal in endosomal compartments, and recycling pathways can resensitize receptors to prolong signaling outputs, as is the case for CXCRs ([@bib9]) and the β-adrenergic receptor ([@bib18]). Furthermore, a recent study has suggested that recycling acts to constantly retarget internalized receptor tyrosine kinases to the leading edge, thus keeping downstream signaling localized during the directional migration of *Drosophila melanogaster* border cells ([@bib13]).

It has been proposed that receptor recycling pathways act to transport integrins forward during cell migration ([@bib4]). Indeed, the localization of αvβ3 integrin to focal complexes at the front of migrating cells is dependent on the short-loop pathway ([@bib31]; [@bib14]), but how this contributes to migration is not yet clear. It is possible that anterograde vesicular transport could contribute directly to persistent migration by constantly retargeting integrins to the leading edge, thus reinforcing the cell\'s polarity axis. Alternatively, trafficking may influence migrational modes by altering integrin signaling. The precise mechanistic link between integrins and Rho signaling is as yet undefined, and endosomal recycling pathways provide an interesting means of reconciling the respective localizations of integrins and their Rho signaling counterparts.

To resolve these issues, we have developed a strategy to target short-loop αvβ3 recycling and have precisely determined its contribution to the speed and persistence of cell migration. Indeed, we find that short-loop recycling has a profound effect on the persistence of migration. This is not, however, because of its ability to transport αvβ3 forward during cell migration but, rather, because it can antagonize α5β1 recycling and the signaling of this integrin to cofilin. Thus, we have revealed that vesicular transport makes a major contribution to cell migration via its capacity to dictate the nature of downstream integrin signaling, which in turn influences the migrational mode of fibroblasts.

Results
=======

Phosphorylation at Ser^916^ is necessary for PKD1--αvβ3 integrin association
----------------------------------------------------------------------------

We previously found that PKD1 can associate specifically with αvβ3 integrin via a motif contained within the C-terminal 14 amino acids of the β3 cytodomain ([@bib31]). This association recruits PKD1 to αvβ3 at endosomes and drives the rapid return of the heterodimer to the plasma membrane in response to growth factor treatment. To further characterize this integrin--kinase interaction, we expressed His-tagged PKD1 in Cos-1 cells and purified the kinase to near homogeneity by Ni-affinity chromatography ([Fig. 1 A](#fig1){ref-type="fig"}). To ensure a preparation of maximally active kinase, Cos-1 cells were treated with phorbol myristate acetate (PMA) for 30 min before lysis in the presence of phosphatase inhibitors. Purified PKD1 bound directly and with high affinity (*K* ~d~ \[apparent\] in the low nanomolar range) to GST-β3 integrin cytodomain ([Fig. 1 B](#fig1){ref-type="fig"}). There was no detectable association between purified active PKD1 and the cytoplasmic sequences of the αv, α5, or β1 integrin subunits, indicating that the interaction was specific for β3 integrin.

![**Phosphorylation of Ser^916^ is required for PKD1 to associate with αvβ3 integrin.** (A) Cos-1 cells expressing His-PKD1 were treated with 1 μM PMA for 15 min to activate the kinase and then lysed in a buffer containing phosphatase inhibitors. His-PKD1 was purified from the lysate by Ni-affinity chromatography and analyzed by SDS-PAGE followed by staining with colloidal Coomassie (left) or by Western blotting with anti-PKD1 (right). (B) GST fusion proteins of the indicated integrin cytodomains were immobilized on the surface of microtitre wells and incubated with serial dilutions of purified His-PKD1. Bound PKD1 was detected by ELISA using antibodies recognizing PKD1, followed by chromogenic detection with *o*-phenylenediamine ([@bib23]). Values are mean ± SEM (*n* \> 5). (C) Purified His-PKD1 was incubated in the presence or absence of alkaline phosphatase and then added to microtitre wells that had been previously coated with GST-β3 cytodomain. Bound PKD1 was detected by ELISA as for B. Values are mean ± SEM (*n* = 4). (D) His-PKD1^WT^ and HisPKD1^916A^ were expressed in Cos-1 cells and purified as for A. Binding to GST-β3 was determined as for B. Two GST-β3 cytodomain constructs were used for these experiments; open and closed symbols indicate binding to GST-β3^727-762^ and GST-β3^749-762^, respectively. Values are mean ± SEM (*n* \> 5). (E) Mouse NIH3T3 fibroblasts were transfected with PKD1^wt^ or PKD1^916A^ in conjunction with human αvβ3 integrin or the αv chain alone. Cells were treated with a combination of PDGF and primaquine for 12 min followed by lysis in a buffer containing 1% octyl β-thioglucopyranoside. Lysates were incubated with magnetic beads coupled to an antibody recognizing human β3 integrin for 2 h at 4°C. Immobilized material was analyzed by Western blotting for PKD1 (top) and β3 integrin (bottom). (F) Purified His-PKD1^wt^ or His-PKD1^916A^ was incubated with GST or GST-c-Jun in the presence of \[^32^P\]ATP. Phosphorylated proteins were visualized by SDS-PAGE followed by autoradiography (bottom), and protein loading was confirmed by staining with Coomassie blue.](jcb1770515f01){#fig1}

After activation with growth factors, cellular PKD1 is phosphorylated at several residues ([@bib28]). As we have previously shown that treatment with a growth factor such as PDGF is necessary for coimmunoprecipitation of αvβ3 and PKD1 ([@bib31]), we sought to determine whether phosphorylation was necessary for integrin binding. Indeed, treatment of PKD1 with alkaline phosphatase (which led to ∼80% dephosphorylation of the kinase \[not depicted\]) reduced the affinity of integrin--kinase association by approximately fivefold ([Fig. 1 C](#fig1){ref-type="fig"}). PKD1 is auto- (and possibly trans-) phosphorylated at Ser^916^ in its C terminus ([@bib16]; [@bib28]; [@bib25]), but no clear cellular role for this has been described. We therefore mutated Ser^916^ of PKD1 to alanine and determined the ability of this mutant kinase to bind to αvβ3 integrin. Indeed, purified PKD1^916A^ had strikingly reduced ability to bind to GST fusion proteins of the β3 integrin cytodomain ([Fig. 1 D](#fig1){ref-type="fig"}). Moreover, when expressed in fibroblasts, PKD1^916A^ did not coimmunoprecipitate with αvβ3 ([Fig. 1 E](#fig1){ref-type="fig"}), indicating that autophosphorylation of this residue is a prerequisite for integrin--kinase association. In agreement with a previous report ([@bib28]), we found that mutation of Ser^916^ had no influence on the PKD1 activity, as determined by the ability of purified PKD1^916A^ to phosphorylate one of its best-characterized substrates, the N-terminal portion of c-Jun ([@bib11]; [Fig. 1 F](#fig1){ref-type="fig"}).

Expression of PKD1^916A^ selectively opposes short-loop recycling of αvβ3
-------------------------------------------------------------------------

Suppression of cellular PKD1 levels by RNAi, expression of catalytically inactive PKD1s, and/or mutant β3 subunits that cannot bind to PKD1 oppose short-loop recycling of αvβ3 ([@bib31]). However, these strategies will be likely to compromise other aspects of PKD1 and integrin signaling, such as the recruitment of c-Src to αvβ3 ([@bib1]) and the role of PKD1 in Golgi transport ([@bib15]). With this in mind, we determined the influence of PKD1^916A^ on integrin recycling via the short-loop pathway but also quantified other indices of integrin, PKD1, and endocytic function. Short-loop αvβ3 recycling was driven by the addition of growth factors such as PDGF and lysophosphatidic acid and by the addition of 10% serum (all of which lead to PKD1 activation) to serum-starved cells ([Fig. 2, A and B](#fig2){ref-type="fig"}). However, after expression of PKD1^916A^, these agents were unable to drive the delivery of αvβ3 to the plasma membrane, indicating that this PKD1 mutant acts in a dominant-negative fashion to oppose growth factor--driven short-loop integrin recycling ([Fig. 2, A and B](#fig2){ref-type="fig"}). Moreover, PKD1^916A^ did not inhibit the return of integrins to the plasma membrane via the long loop ([Fig. 2 C](#fig2){ref-type="fig"}), the recycling of internalized \[^125^I\]Tfn ([Fig. 2 D](#fig2){ref-type="fig"}), or the endocytosis of integrins and the Tfn-R (not depicted), indicating that this mutant PKD1 selectively targets short-loop αvβ3 recycling.

![**PKD1^916A^ opposes short-loop recycling of αvβ3 integrin without inhibiting long-loop recycling or VSVG transport.** (A) NIH3T3 fibroblasts were transfected with αvβ3 (human sequence) integrin in combination with PKD1^wt^ or PKD^916A^ as indicated. Short-loop recycling in the presence or absence of 10 ng/ml PDGF-BB, 1 mg/ml lysophosphatidic acid (LPA), or 10% FCS was determined as described previously ([@bib31]). To determine recycling of endogenous mouse αvβ3, NIH3T3 fibroblasts were transfected with PKD1^wt^ or PKD1^916A^ using the Nucleofector. Short-loop recycling of mouse αvβ3 in the presence and absence of 10% FCS was determined as described by [@bib23]. (B) To evaluate the stimulus-dependent component of recycling, the data from A are presented after subtraction of the appropriate basal values. (C) Cells were transfected with αvβ3 (left) or α5β1 (right) in combination with PKD^wt^ or PKD^916A^. Long-loop recycling was determined as described previously ([@bib23], [@bib24]). (D) NIH3T3 fibroblasts were transfected with PKD1^wt^ or PKD1^916A^ using the Nucleofector. Cells were then incubated with \[^125^I\]transferrin for 1 h at 4°C to label the transferrin receptor at the cell surface. The tracer was allowed to internalize for 15 min at 22°C, and its return to the plasma membrane was determined as described previously ([@bib24]). (E) NIH3T3 fibroblasts were transfected with ts045 VSVG and placed at 40°C for 24 h. Cells were then incubated at 32°C for the indicated times and placed on ice. Surface proteins were labeled by incubation with NHS-Biotin (0.2 mg/ml) for 30 min at 4°C, and biotinylated VSVG was detected by capture ELISA using microtitre wells coated with a polyclonal antibody recognizing VSVG. Values are mean ± SEM (*n* \> 10).](jcb1770515f02){#fig2}

To gain information as to how PKD1^916A^ exerts this dominant-negative effect on αvβ3 recycling, we overexpressed His-tagged PKDs and measured activation of the endogenous kinase using a reporter antibody recognizing activating phosphorylations within the kinase domain of PKD1 (phospho-Ser^744/8^). Indeed, expression of His-PKD1 or His-PKD^916A^ strongly suppressed phosphorylation of the endogenous kinase at Ser^744/8^ (Fig. S1, available at <http://www.jcb.org/cgi/content/full/jcb.200609004/DC1>), indicating that these overexpressed recombinant kinases can compete effectively with endogenous PKD1 for the upstream activating kinase (PKC*ɛ*) that phosphorylates these residues, thus providing a mechanistic rationale for the dominant-negative influence of PKD1^916A^ on integrin αvβ3 recycling and function.

To assess TGN to plasma membrane transport, we used vesicular stomatitis virus G protein (VSVG) from the temperature-sensitive (ts) 045 mutant of vesicular stomatitis virus, which is misfolded and retained in the ER at 40°C but moves out of the ER, though the Golgi complex and to the plasma membrane upon temperature shift to 32°C ([@bib20]). ts045 VSVG appeared at the plasma membrane over a time course of ∼2 h after shift to 32°C and, consistent with the previously established role of PKD1 in TGN to plasma membrane transport ([@bib15]), this was markedly reduced by expression of a short hairpin RNA (shRNA) targeting PKD1 ([Fig. 2 E](#fig2){ref-type="fig"}). However, expression of PKD1^916A^ did not suppress delivery of VSVG to the plasma membrane ([Fig. 2 E](#fig2){ref-type="fig"}), indicating that although this mutant kinase completely ablated growth factor--driven αvβ3 recycling ([Fig. 2, A and B](#fig2){ref-type="fig"}), it did not compromise PKD1\'s action at the TGN. Collectively, these data highlight the potential effectiveness of PKD1^916A^ as a molecular tool, not only to enable comparison of the respective roles played by PKD1 in Golgi transport and integrin recycling but, more particularly, to determine the contribution made by short-loop αvβ3 recycling to cell migration.

Short-loop αvβ3 recycling influences the persistence of cell migration
----------------------------------------------------------------------

We ([@bib31]) and others ([@bib21]) previously determined that suppression of PKD1 leads to reduced cell migration and an impaired ability of migrating fibroblasts to establish their characteristic fan-like morphology. To determine the precise contribution of short-loop αvβ3 recycling to cell migration, we manipulated αvβ3-PKD1 association and Rab4-dependent recycling in fibroblasts, collected time-lapse videos of these cells migrating into a scratch wound, and followed individual cell movement using cell-tracking software. Expression of PKD1^916A^ compromised the ability of cells to migrate directionally into the wound ([Fig. 3](#fig3){ref-type="fig"}) and, rather than migrating with the fan-like morphology characteristic of fibroblasts ([Fig. 3 A](#fig3){ref-type="fig"}, arrow at 300-min time point), PKD1^916A^-expressing cells appeared to migrate by extending thin and often pointed protrusions ([Fig. 3 B](#fig3){ref-type="fig"}, arrow at 250-min time point). We therefore proceeded with a more in-depth analysis involving the assembly of overlays of representative trajectories described by cells during the first 5 h of their migration into the wound ([Fig. 4 A](#fig4){ref-type="fig"}) and the extraction of parameters such as the persistence and speed of migration from track plots ([Fig. 4, B and C](#fig4){ref-type="fig"}), persistence being defined as the ratio of the vectorial distance traveled to the total path length described by the cell. Untransfected fibroblasts and those expressing wild-type PKD1, Rab4, or control shRNA migrated largely perpendicular to the wound edge and maintained a high degree of persistence ([Fig. 4 A](#fig4){ref-type="fig"}). However, suppression of short-loop αvβ3 recycling, by PKD1^916A^, RNAi of PKD1, or dominant-negative Rab4, markedly reduced persistent migration such that the cells migrated randomly for up to 5 h after wounding. It is interesting to note that expression of PKD1^916A^ or Rab4^121I^ (both of which suppress short-loop recycling of αvβ3) reduced persistence without greatly affecting the migration speed, whereas RNAi of PKD1 (which affects both integrin recycling and TGN anterograde transport) reduced both the speed and persistence of migration ([Fig. 4, B and C](#fig4){ref-type="fig"}). Moreover, migrational persistence was unaltered by inhibition of long-loop recycling by dominant-negative Rab11, indicating that this key parameter of cell movement relies particularly on the short-loop pathway. To further investigate the requirement for short-loop recycling in migrational persistence, we used a strategy by which endogenous levels of mouse αvβ3 integrin were reduced by expression of a shRNA targeting the mouse sequence of β3 integrin (Fig. S2, available at <http://www.jcb.org/cgi/content/full/jcb.200609004/DC1>), followed by expression of either the wild-type human αvβ3 heterodimer or β3 integrins with cytodomain mutations that reduce binding to PKD1. Clearly, suppression of αvβ3 levels by shRNAi profoundly reduced migrational persistence without much affecting the speed of migration ([Fig. 4](#fig4){ref-type="fig"}), and persistence was completely restored by expression of human αvβ3 integrin or a β3 integrin mutant (β3^G761A^; [@bib31]) with an unaltered ability to recruit PKD1 ([Fig. 4](#fig4){ref-type="fig"}). In contrast, β3 integrin mutants (β3^Y759A^ and β3^1-760^) that cannot bind PKD1 and are consequently unable to enter the short-loop pathway ([@bib31]) do not restore persistent migration in β3 knockdown cells ([Fig. 4, A and B](#fig4){ref-type="fig"}). Moreover, a similar reduction in persistence was observed after the addition of a cyclic peptide (cyclo-RGDfN^me^V) that competitively inhibits binding of ECM ligands to αv (but not β1) integrins ([Fig. 4, A and B](#fig4){ref-type="fig"}; [@bib8]), indicating that αvβ3 needs not only be competent to recycle via the short loop but must also engage ligand to support persistent and directional fibroblast migration.

![**Effect of PKD^916A^ on the ability of fibroblasts to initiate directional migration after wounding of a monolayer.** NIH3T3 fibroblasts were transfected with either PKD1^wt^ (A) or PKD1^916A^ (B) using the Nucleofector and grown to confluence over 36 h. Confluent monolayers were wounded with a plastic pipette tip, and the cells were allowed to migrate into the wound. The cells were observed by time-lapse video microscopy, with frames being captured at 20-min intervals. The position of the cell nucleus was followed using cell tracking software, and cumulative track plots of individual cells are displayed in red. The white arrow in (A, 300 min) indicates a cell with a fan-like lamellipodium, the arrow in (B, 250 min) denotes one of the protrusions that form during the migration of PKD^916A^-expressing cells. Bar, 20 μm.](jcb1770515f03){#fig3}

![**Blockade of αvβ3 integrin short-loop recycling or its ability to engage ECM ligand suppresses the migrational persistence of fibroblasts.** Using the Nucleofector, NIH3T3 fibroblasts were transfected with PKD1^wt^, PKD1^916A^, a control shRNA (shCON), a shRNA-targeting PKD1, Rab4^wt^, or dominant-negative Rab4^121I^ or Rab11^124I^. Alternatively, cells were transfected with a shRNA targeting mouse β3 integrin (sh*m*β3) either alone or in combination with human αv integrin and the indicated mutants of human β3 integrin (*h*β3). Confluent monolayers were wounded with a plastic pipette tip, and the cells were allowed to migrate into the wound in DME supplemented with 10% FCS in the absence or presence of 1 μM cyclo-Arg-Gly-Asp-D-Phe-N(Me)-Val (cRGDfN^me^V) or vehicle control (DMSO). The cells were observed by time-lapse video microscopy, the movement of individual cells followed using cell-tracking software, and this is presented as overlays of representative trajectories described by cells during the first 5 h of their migration into the wound (A). The persistence (B) and speed (C) of migration were extracted from the track plots. Persistence is defined as the ratio of the vectorial distance traveled to the total path length described by the cell. Values are mean ± SEM (*n* \> 150 track plots). Bar, 50 μm.](jcb1770515f04){#fig4}

It is now generally accepted that there is considerable interplay between cytoskeletal events directing cell polarization and the vesicular transport machinery. Indeed, the way that receptors are targeted to the plasma membrane can influence the generation and maintenance of cell polarity and vice versa. We therefore determined whether blockade of short-loop αvβ3 recycling altered the ability of cells to polarize their microtubule organizing center (MTOC) in response to wounding. Anterior orientation of the MTOC was detectable shortly after wounding, and this reached a maximum (which was largely maintained) after 2 h ([Fig. 5, A and B](#fig5){ref-type="fig"}). The rate at which MTOC orientation was initiated and the extent to which it was maintained was unaffected by expression of either PKD1^916A^ or Rab4^121I^ ([Fig. 5](#fig5){ref-type="fig"}). This clearly indicated that integrin recycling plays no role in the ability of these cells to sense the wound and polarize their microtubular cytoskeleton accordingly. Moreover, as we continued to track cell movement, it became clear that cells with compromised short-loop recycling, after having migrated randomly for ∼5 h, began to migrate persistently into the wound ([Fig. 6](#fig6){ref-type="fig"}). Collectively, these data indicate that although short-loop αvβ3 recycling is not required for wound sensing or the eventual acquisition of a proper migratory phenotype, it is likely to alter signaling events that influence the balance between persistent versus random migration.

![**Short-loop αvβ3 recycling is not required for orientation of the MTOC.** NIH3T3 fibroblasts were transfected with PKD1^wt^, PKD1^916A^, or dominant-negative Rab4^121I^ or Rab11^124I^ using the Nucleofector and grown to confluence over 36 h. Confluent monolayers were wounded with a plastic pipette tip, and the cells were allowed to migrate into the wound for 2 h (A and C) or for the times indicated in B. Cells were fixed in ice-cold methanol and the MTOC (centrosomes) visualized by immunofluorescence using an antibody recognizing γ-tubulin (red), and the nucleus was counterstained with DAPI (blue). The position of each centrosome in the first row of cells migrating into the wound was scored according to its position relative to the nucleus. Values are mean ± SEM (*n* \> 100 cells). Bar, 10 μm.](jcb1770515f05){#fig5}

![**Cells with compromised short-loop recycling are able to migrate persistently at later times after wounding.** Representative track plots (A) and values of migrational persistence (B) and speed (C) were obtained as for [Fig. 4](#fig4){ref-type="fig"}, but with cell movement being followed between 5 and 10 h after wounding. The track plots are from the same cells as those presented in [Fig. 4](#fig4){ref-type="fig"}. Values are mean ± SEM (*n* \> 150 track plots). Bar, 100 μm.](jcb1770515f06){#fig6}

Short-loop recycling of αvβ3 opposes α5β1 recycling and resultant signaling to phosphocofilin
---------------------------------------------------------------------------------------------

Whether a cell chooses persistent over random migration likely depends on the balance between αvβ3 and α5β1 integrin signaling. It is thought that αvβ3 promotes persistent and directional migration and that this requires appropriate levels of Rac signaling downstream of this integrin ([@bib7]). Conversely, α5β1 tends to promote random migration, and this is a consequence of its ability to activate the Rho--ROCK--cofilin pathway ([@bib7]). Indeed, the increased cellular phospho-Ser^3^-cofilin levels that result from α5β1-driven activation of Rho (and expression of a Ser^3^-phosphomimetic mutant of cofilin) strongly suppress persistence and promote random migration ([@bib7]). As it is possible that the nature of signaling downstream of integrins may be dictated by their trafficking, we investigated whether the influence of the short-loop αvβ3 recycling pathway on migrational persistence could be indirectly implemented through α5β1 recycling and signaling. Indeed, manipulations that compromise the short-loop recycling of αvβ3 (such as expression of PKD1^916A^, dominant-negative Rab4, or PKD1 binding--deficient β3 integrin mutants β3^759A^ and β3^1-760^) acted to increase the rate at which α5β1 was returned to the plasma membrane by at least twofold ([Fig. 7 A](#fig7){ref-type="fig"}). Conversely, overexpression of wild-type αvβ3 or a "control" β3 integrin mutant (β3^761A^) that binds to PKD1 profoundly suppressed α5β1 recycling ([Fig. 7 A](#fig7){ref-type="fig"}). Furthermore, in experiments where cells were either spread onto fibronectin for 30 min or wounded with a pipette tip and then analyzed by Western blotting, phospho-Ser^3^-cofilin levels were markedly promoted by inhibition of αvβ3 recycling, and the use of an α5β1 function-blocking antibody (mAb16) and a ROCK inhibitor (Y27632) indicated that this increase in phosphocofilin was dependent on both α5 integrin and ROCK ([Fig. 7, B and C](#fig7){ref-type="fig"}). Moreover, PKD1^916A^-driven increases in phosphocofilin were only detectable up to 5 h after wounding (i.e., during the period in which cells were migrating randomly); thereafter, levels of this index of ROCK signaling were indistinguishable from that of control cells ([Fig. 7 D](#fig7){ref-type="fig"}). Collectively, these observations show a clear reciprocal relationship between short-loop αvβ3 recycling and the trafficking of α5β1 and ability of this integrin to act via ROCK to promote cofilin phosphorylation. In addition, the time course of Rho signaling downstream of α5β1 inversely correlates with migrational persistence in a way that accounts for the resumption of this mode of migration at later times after monolayer wounding (compare [Fig. 3 B](#fig3){ref-type="fig"} and [Fig. 6](#fig6){ref-type="fig"} with [Fig. 7 D](#fig7){ref-type="fig"}).

![**Inhibition of short-loop recycling of αvβ3 promotes α5β1 recycling and α5β1-dependent ROCK--cofilin signaling.** (A) NIH3T3 fibroblasts were transfected with α5β1 integrin (human sequence) together with PKD1^wt^, PKD1^916A^, Rab4^wt^, Rab4^121I^, a nontargeting shRNA (shCON), or a shRNA targeting mouse β3 integrin (sh*m*β3) either alone or in combination with human αv integrin and the indicated mutants of human β3 integrin (*h*β3). Long-loop recycling of the transfected human α5β1 was then determined as described previously ([@bib24]). To determine recycling of endogenous mouse α5β1 (top middle), NIH3T3 fibroblasts were transfected with PKD1^wt^ or PKD1^916A^ using the Nucleofector. Long-loop recycling of endogenous mouse α5β1 was then determined as described by [@bib23]. Values are mean ± SEM (*n* = 10). (B--D) Using the Nucleofector, cells were transfected with PKD1^wt^, PKD1^916A^, Rab4^wt^, Rab4^121I^, a nontargeting shRNA (shCON), or a shRNA targeting mouse β3 integrin (sh*m*β3) either alone or in combination with human αv integrin and the indicated mutants of human β3 integrin (*h*β3). Cells were grown to confluence over 36 h, trypsinized, incubated in suspension for 45 min, and plated onto plastic surfaces coated with fibronectin (10 μg/ml in PBS) for 30 min (B). Where indicated, 2 μM Y27632, 2 μg/ml mAb16, or vehicle control (DMSO) were included 15 min before and throughout the plating period (B). Alternatively, monolayers were extensively wounded (evenly spaced 500-μm wounds; wounded area was ∼30% of monolayer area) with a plastic pipette tip, and cells were allowed to migrate into the wound for 1 h (C) or for the times indicated in D. Cells were lysed, and the cellular content of phospho-Ser^3^-cofilin (top) and β-actin (bottom) was determined by Western blotting.](jcb1770515f07){#fig7}

Given these relationships, we sought to directly determine whether the loss of persistence resulting from inhibition of the short-loop pathway was a consequence of increased α5β1 signaling. Indeed, addition of mAb16 or Y27632 restored persistent migration in cells expressing PKD1^916A^, shRNAs targeting PKD1, dominant-negative Rab4, or PKD1 binding--deficient β3 integrin mutants ([Fig. 8, A and B](#fig8){ref-type="fig"}). Moreover, persistent migration was partially restored by inhibition of α5β1 or ROCK signaling in cells treated with cyclo-RGDfNmeV to block the interaction of αvβ3 with its ECM ligands ([Fig. 8, A and B](#fig8){ref-type="fig"}). These data clearly show that the requirement for αvβ3 short-loop recycling (and its ligand engagement) in persistent migration is neither direct nor absolute but is mediated via the ability of this pathway (when active) to antagonize α5β1 integrin recycling and subsequent signaling to the ROCK cofilin pathway ([Fig. 9 A](#fig9){ref-type="fig"}). Thus, when the αvβ3 short loop is blocked, the resulting deregulation of α5β1 recycling and signaling promotes random migration in favor of persistence ([Fig. 9 B](#fig9){ref-type="fig"}).

![**α5β1 function-blocking antibody (mAb16) and ROCK inhibitor (Y27632) restore persistent migration in cells with compromised short-loop recycling.** Using the Nucleofector, NIH3T3 fibroblasts were transfected with PKD1^wt^, PKD1^916A^, a shRNA targeting PKD1 (shPKD1), Rab4^121I^, or a shRNA targeting mouse β3 integrin (sh*m*β3) either alone or in combination with human αv integrin and the indicated mutants of human β3 integrin (*h*β3). Representative track plots (A) and values for migrational persistence (B) and speed (C) during the first 5 h after monolayer wounding were obtained as for [Fig. 4](#fig4){ref-type="fig"}. Where indicated, 2 μM Y27632, 2 μg/ml mAb16, vehicle control (DMSO), or 1 μM cyclo-Arg-Gly-Asp-D-Phe-N(Me)-Val (cRGDfN^me^V) were added immediately after wounding. Values are mean ± SEM (*n* \> 75 track plots). Bar, 50 μm.](jcb1770515f08){#fig8}

![**Schematic summary of the relationship between αvβ3 and α5β1 integrin recycling, ROCK signaling, and migrational persistence in fibroblasts.** (A) αvβ3 integrin is internalized and recycles rapidly via the short-loop pathway under the control of Rab4 and PKD1 to engage ECM ligand (VN/FN). This process exerts a tonic inhibition on the return of internalized α5β1 integrin from the Rab11 compartment to the plasma membrane. Under these circumstances, α5β1 has little or no ability to promote cofilin phosphorylation via the ROCK pathway, and cells migrate persistently. (B) After disruption of the short-loop pathway (by RNAi of PKD1, expression PKD1^916A^, dominant-negative Rab4, or β3 mutants that cannot bind PKD1), reduction of αvβ3 levels by shRNA or pharmacological blockade of its interaction with ECM ligand (c-RGDfN^me^V), the rate at which α5β1 recycles from the Rab11 compartment is increased (bold arrow). Under these circumstances, α5β1 promotes ROCK-dependent cofilin phosphorylation and migrational persistence is suppressed. (C) When short-loop recycling or αvβ3 engagement is suppressed, addition of an α5β1 function-blocking antibody (mAb16) or a ROCK inhibitor (Y27632) reduces phosphocofilin levels, and the cells migrate persistently.](jcb1770515f09){#fig9}

Discussion
==========

PKD1 is thought to promote the fission of vesicles emanating from the TGN and thus enhance the transport of Golgi-derived cargo to the plasma membrane ([@bib15]). However, this has been controversial because of difficulties in demonstrating localization of PKD1 to the TGN ([@bib22]) and the fact that evidence supporting a role for the kinase in Golgi to plasma membrane transport has come primarily from the use of kinase-dead mutants. Despite these caveats, the recent identification of the Golgi-localized phosphatidylinositol 4-kinase IIIβ as a physiological PKD substrate ([@bib10]) and our observation that RNAi of PKD1 suppresses plasma membrane delivery of VSVG protein clearly support a role for this kinase in Golgi to plasma membrane transport. Furthermore, observations of TGN-derived vesicles being transported toward the lamellipodium as fibroblasts migrate ([@bib26]; [@bib21]) demand that a contribution of PKD1-regulated Golgi transport to cell migration must be considered. Here, we show that the functional significance of autophosphorylation of PKD1 at Ser^916^ is to regulate direct interaction with αvβ3 and thus influence integrin recycling. However, as phosphorylation at this residue has no detectable effect on the transport of VSVG protein from the TGN to the plasma membrane, we have been able to use PKD1^916A^ as a molecular tool to address key questions concerning the relative contributions of PKD1-regulated Golgi transport and integrin recycling to cell migration. First, differential effects of PKD1^916A^ on αvβ3 recycling and VSVG transport indicate that this integrin is unlikely to return to the plasma membrane via the TGN (as is the case for certain recycling proteins). Second, suppression of PKD1 activity by expression of kinase-dead PKD1 or by RNAi influences both speed and directionality, whereas expression of PKD1^916A^ selectively targets migrational persistence. This indicates that PKD1 controls αvβ3 recycling to influence directionality, with PKD1-regulated Golgi traffic acting to additionally enhance the migration speed of fibroblasts.

Although the surface distribution of αvβ3 in migrating fibroblasts is polarized toward the cell front ([@bib31]), Rab4 is tightly localized to endosomes in the juxtanuclear region that face the direction of travel (unpublished data). Thus, the relevant matrix receptors and the endosomes that traffic them are distributed along the lamellipodial--perinuclear axis of the migrating cell. Moreover, this level of organization depends on flux of αvβ3 through the short loop, as expression of PKD1^916A^ or PKD1 binding--deficient β3 integrins dissipates the polarized distribution of surface αvβ3 ([@bib31]; unpublished data) and delocalizes Rab4 endosomes from the anterior perinuclear zone (unpublished data). Given these observations, it is tempting to suggest that the short loop directly reinforces persistent migration by transporting αvβ3 to and from the lamellipodium along the axis of polarity. However, inhibition of α5β1 signaling in cells with compromised αvβ3 short-loop recycling enables persistent migration despite a lack of proper polarization of αvβ3 and Rab4. Therefore, although the short loop may indeed transport αvβ3 toward the leading edge, this process is not an absolute requirement for persistent migration when the α5β1--ROCK--cofilin pathway is down-regulated. In addition to generating polarized surface distributions and restricting signaling spatially ([@bib13]), endocytosis/recycling can oppose receptor desensitization ([@bib18]), in part by acting to clear occupied receptors of ligand and returning them to the plasma membrane competent to bind fresh ligand. As our data indicate that αvβ3 needs to be both rapidly cycling and competent to engage ligand to promote persistent migration, it is probable that short-loop recycling acts to continuously resensitize αvβ3 to ligand occupation, thus maintaining sufficient αvβ3 downstream signaling to tonically inhibit α5β1 recycling.

Epithelial cells expressing αvβ3 (and not α5β1) migrate persistently, and the appropriate activation of Rac by this integrin is likely to be key to this process ([@bib7]). Conversely, if cells express α5β1 (and not αvβ3), they migrate randomly because of activation of the ROCK--cofilin pathway and the antagonistic effect this has on Rac-driven stabilization of the lamellipod ([@bib7]). Therefore, under situations where the expression profile of fibronectin-binding integrins is biased, one is able to predict a cell\'s migratory behavior. However, in fibroblasts and endothelial cells, α5β1 and αvβ3 expression is closely matched and, because of the relatively small size of the intracellular pool of these integrins (∼10 and 20% of the quantity of surface integrin for αvβ3 and α5β1, respectively) and their capacity to reach the plasma membrane via more than one route, experimental manipulations that target particular integrin recycling pathways (such as those used in the present study) do not greatly alter the amount of αvβ3 or α5β1 that is expressed at the cell surface (Fig. S3, available at <http://www.jcb.org/cgi/content/full/jcb.200609004/DC1>). There is a clear reciprocal relationship between the rates at which αvβ3 and α5β1 recycle; i.e., blockade of αvβ3 short-loop recycling doubles the rate at which α5β1 returns to the plasma membrane via the Rab11 pathway. The mechanistic connection underlying this relationship is not mediated by alterations in PKB/GSK-3β signaling (unpublished data), but the rapidity of α5β1 recycling is closely correlated with the intensity of cofilin signaling downstream of this integrin. Thus, the way in which an integrin is handled by the recycling pathway may dictate its ability to connect with and activate Rho-signaling pathways. Furthermore, our data suggest that the contribution of recycling to migrational persistence is more easily interpreted in terms of its influence on the signaling capacity of integrins rather than processes such as vectorial transport of matrix receptors to the leading edge and their subsequent incorporation into the adhesive and migratory machine. It is now becoming more apparent that the characteristics of signaling downstream of receptor tyrosine kinases and G protein--coupled receptors depend on how they are trafficked through the endosomal and recycling pathways ([@bib17]). In this regard, it will be interesting to investigate a potential role for the Rab11 pathway in resensitization and prolongation of α5β1 signaling and whether recycling endosomes constitute a platform for assembly of signalosomes that include guanine nucleotide exchange factors or GTPase-activating proteins for RhoA. In addition to Rho GTPase signaling, ligation of α5β1 integrin has been linked to activation of Calmodulin-dependent protein kinase II (CamKII) in myeloid cells ([@bib3]). Furthermore, as ligation of αvβ3 strongly suppresses the ability of α5β1 to communicate with CamKII, the possibility that this and other examples of integrin "cross-talk" involve alterations in the endo--exocytic behavior of α5β1 should be considered.

Using a strategy to selectively target the Rab4-dependent short-loop recycling of αvβ3 integrin, we demonstrate a clear connection between this pathway and a persistent mode of fibroblast migration. Short-loop recycling exerts its influence by counteracting the trafficking and signaling of another integrin, the α5β1 heterodimer, and there is no obligatory requirement for short-loop αvβ3 recycling when α5β1 signaling is compromised. These data show that the short loop does not form part of the machinery integral to persistent cell migration, but acts to dictate the nature of integrin downstream signaling, which in turn influences the cell\'s decision to migrate with persistence or to move randomly on 2D matrices. The ability of β1 integrins to signal to RhoA determines the mode of tumor cell invasiveness ([@bib29]), and a key challenge for the future will be to determine the influence that recycling pathways have on integrin signaling and the choice between elongated and amoeboid migration of tumor cells through 3D matrices.

Materials and methods
=====================

Plasmids
--------

αv, β3, α5, and β1 integrins and Rab4, Rab4^121I^, and Rab11^124I^ were in pcDNA3 are as described by [@bib23] and [@bib31]. The mouse sequences for PKD1 and PKD1^916A^ were tagged with a hexa-Histidine at the 5′ end (N terminus), cloned into pcDNA3, and verified by sequencing. The shRNA mU6pro vector targeting PKD1 and the validation of its efficacy is described by [@bib31], and the shRNA sequences targeting mouse β3 integrin (5′-CAGCTCATTGTTGATGCTT-3′ and 5′-GTCAGCCTTTACCAGAATT-3′) were cloned into the mu6pro vector as described by [@bib32]. ts045-VSVG is as described previously ([@bib20]) and was a gift from J. Lippincott-Schwartz (National Institutes of Health, Bethesda, MD). All plasmids were purified by CsCl banding before transfection into NIH3T3 fibroblasts by Fugene 6 or Amaxa Nucleofection. PCR-amplified DNA fragment corresponding to the indicated regions of the human sequence of β3 integrin were subcloned into the pGEX-4T-1 vector. GST fusion proteins were expressed in *Escherichia coli* strain BL-21 and purified as described previously ([@bib30]).

Expression and purification of His-PKD1
---------------------------------------

Cos-1 cells transfected with His-PKD1 or His-PKD1^916A^ were treated with 1 μM PMA for 15 min to activate the kinase and then lysed in 200 mM NaCl, 75 mM Tris, 15 mM NaF, 1.5 mM Na~3~VO~4~, 7.5 mM EDTA, 7.5 mM EGTA, 1.5% Triton X-100, 0.75% Igepal CA-630, 50 μg/ml leupeptin, 50 μg/ml aprotinin, and aminoethyl benzene sulfonyl fluoride (AEBSF) and scraped from the dish with a rubber policeman. Lysates were passed three times through a 27-gauge needle and clarified by centrifugation at 10,000 *g* for 10 min. The clarified lysates were loaded into a 1-ml His-TRAP affinity column (GE Healthcare), and the kinase was eluted with a linear gradient of imidazole. 1-ml fractions were collected, and the peak of purified His-PKD1 was identified by SDS-PAGE followed by staining with colloidal Coomassie. The kinase was dialysed overnight into kinase buffer (25 mM Hepes, pH 7.4, containing 25 mM MgCl~2~, 0.5 mM Na~3~VO~4~, 0.5 mM EDTA, and 0.5 mM DTT), glycerol was added to 50% (vol/vol), and the kinase was stored at −20°C. Kinase assays to assess the catalytic activity of PKD1 were performed in kinase buffer in the presence of 100 μM ATP, 4.4 μCi γ-\[^32^P\]ATP, and 3 μg c-Jun 1--89 GST fusion protein (a gift from M. Dickens, University of Leicester, Leicester, UK) per reaction. Reaction products were resolved is 12% SDS-polyacrylamide gels, which were dried and exposed to x-ray film to visualize bands.

Microtitre ELISA
----------------

GST-integrin cytodomain fusion proteins were bound at saturating concentrations to wells of microtitre plates (Immunol. 2; Dynatech Laboratories) in 0.05 M Na~2~CO~3~, pH 9.6, at 4°C, and the wells were blocked with PBS containing 0.1% (vol/vol) Tween-20 (PBS-T). Various amounts of purified His-PKD1 or His-PKD1^916A^ were added to the wells in PBS-T and incubated for 1 h at 15°C. After three washes with PBS-T, PKD1 was detected by serial incubations with polyclonal rabbit anti-PKCμ (sc-639; Santa Cruz Biotechnology, Inc.) and horseradish peroxidase--conjugated anti-rabbit IgG, followed by chromogenic reaction with ortho-phenylenediamine as described previously ([@bib23]).

Immunoprecipitations
--------------------

Cells were grown to 90% confluence, serum-starved for 30 min, and treated with a combination of 10 ng/ml PDGF-BB and 0.6 mM primaquine for 12 min. After this, cells were washed twice in ice-cold PBS, lysed in 200 mM NaCl, 75 mM Tris, 15 mM NaF, 1.5 mM Na~3~VO~4~, 7.5 mM EDTA, 7.5 mM EGTA, 1.0% octyl β-thioglucopyranoside, 50 μg/ml leupeptin, 50 μg/ml aprotinin, and AEBSF and subjected to immunoprecipitation using magnetic beads coupled to a mouse anti-human β3 integrin monoclonal antibody (clone VI-PL2; BD Biosciences) as described previously ([@bib31]). Unbound proteins were removed by extensive washing in octyl β-thioglucopyranoside--containing buffer and specifically associated proteins resolved by SDS-PAGE (8% gels under reducing conditions for detection of PKD1; 6% gels under nonreducing conditions for β3 integrin) and analyzed by Western blotting as described previously ([@bib31]).

Cell culture and transfection
-----------------------------

NIH3T3 mouse fibroblasts and Cos-1 cells were grown in DME with 10% (vol/vol) fetal calf serum and 100 U/ml penicillin, 100 μg/ml strepto mycin, and 0.25 μg/ml amphotericin B at 37°C with 10% CO~2~. For integrin recycling assays, immunoprecipitations, and preparation of purified PKD1, cells were grown to 50% confluence, fed with fresh DME containing 10% (vol/vol) fetal calf serum, and transfected using Fugene 6 (Roche Diagnostics) according to the manufacturer\'s instructions. The ratio of Fugene 6 to DNA was maintained at 3 μl Fugene/1 μg DNA. For cell migration studies and measurement of phosphocofilin signaling, transfections were performed using the Nucleofector system (Amaxa). In brief, cells were grown to 80% confluence, removed by trypsinization, washed in PBS, and resuspended in Amaxa solution R with 5 μg DNA. After electroporation (in the Nucleofector; program T-20), the cells were replated in 6-well dishes.

Receptor recycling and Golgi transport assays
---------------------------------------------

Integrin recycling assays were performed as described previously ([@bib23]). ^125^I-transferrin recycling assays were performed essentially as described previously ([@bib27]) with some modifications. In brief, serum-starved cells were incubated with ^125^I-labeled transferrin (0.1 μCi/well; NEX212 \[NEN Life Science Products\]) for 1 h at 4°C in PBS with 1% (wt/vol) BSA. The tracer was allowed to internalize for 15 min at 22°C (to label early endosomes) or 30 min at 37°C (to label the recycling compartment). Tracer remaining at the cell surface was removed by incubation with acid-PBS (corrected to pH 4.0 by the addition of HCl) at 4°C for 6 min, and the tracer was allowed to recycle at 37°C in serum-free DME supplemented with 1% BSA and 50 μM desferoxamine (D9533; Sigma-Aldrich). The quantity of ^125^I recycled into the medium is expressed as a percentage of the number of counts incorporated during the internalization period.

For measurement of Golgi transport, NIH3T3 fibroblasts were transfected with ts045 VSVG and placed at 40°C for 24 h. Cells were then incubated at 32°C for the indicated times and placed on ice. Surface proteins were labeled by incubation with 0.2 mg/ml NHS-Biotin (EZ-Link Sulfo-NHS-Biotin \[21217\]; Pierce & Warriner) in PBS for 30 min at 4°C, and biotinylated VSVG was detected by capture ELISA using microtitre wells coated with a polyclonal antibody recognizing VSVG (ab3861; Abcam).

Time-lapse microscopy and track-plot analysis
---------------------------------------------

Confluent monolayers were wounded with a plastic pipette tip and placed on the stage of an inverted microscope (Axiovert S100; Carl Zeiss MicroImaging, Inc.) in an atmosphere of 5% CO~2~ at 37°C. Cells were observed using a 20× phase-contrast objective, and images were collected every 20 min using a digital camera (C4742-95; Hamamatsu). Videos were generated and cell tracks analyzed using Andor Bioimaging software. The selective αv integrin antagonist cyclic peptide, cyclo-Arg-Gly-Asp-D-Phe-N(Me)-Val (cRGDfN^me^V), was as described by [@bib8] and was added to the monolayers shortly after wounding at a concentration of 1 μM.

Analysis of MTOC polarization
-----------------------------

Wounded monolayers were maintained at 37°C for various times and fixed in ice-cold methanol. Fixed cells were incubated with an anti--γ-tubulin monoclonal antibody (clone GTU-88; Sigma-Aldrich), followed by a Texas red--conjugated secondary antibody and counterstaining with DAPI to visualize nuclei. The percentage of cells with the MTOC positioned in quadrants facing the wound (front) or at the cell rear (back) or neither (middle) with respect to the position of the nucleus was determined by visual examination of images captured on an epifluorescence microscope (Axiophot; Carl Zeiss MicroImaging, Inc.).

Measurement of phosphocofilin signaling
---------------------------------------

Cells transfected using the Nucleofector were trypsinized, incubated in suspension for 45 min, and plated onto plastic surfaces coated with 10 μg/ml fibronectin. Where indicated, 2 μM Y27632 (Calbiochem) or 2 μg/ml mAb16 (a gift from K. Yamada, National Institutes of Health, Bethesda, MD) were included 15 min before and throughout the plating period. Alternatively, monolayers were extensively wounded (evenly spaced 500-μm wounds; wounded area was ∼30% of monolayer area) with a plastic pipette tip, and cells were allowed to migrate into the wound for various times. Cells were lysed and subjected to Western blotting followed by detection with an antibody recognizing phospho-Ser^3^-cofilin (3311; Cell Signaling Technologies).

Online supplemental material
----------------------------

Fig. S1 shows that overexpression of recombinant His-PKD1s inhibits activation of endogenous PKD1. Fig. S2 shows use of shRNAi to suppress cellular levels of mouse αvβ3 integrin. Fig. S3 shows the influence of mutant Rab4 and PKD1 on the surface expression of αvβ3 and α5β1 integrins. Fig. S4 shows coimmunoprecipitation of endogenous PKD1 with endogenous mouse αvβ3 integrin. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200609004/DC1>.
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